| Dr Robert Thomas Buckley, MD | |
|
1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 | |
| (808) 433-2806 | |
| Not Available |
| Full Name | Dr Robert Thomas Buckley |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 12 Years |
| Location | 1 Jarrett White Rd, Tripler Army Medical Center, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790051266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | ML60281151 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harborview Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Researchers from the University of Zurich and University Children's Hospital Zurich have discovered the first X-chromosome-inherited type of the congenital disease osteogenesis imperfecta, also known as brittle-bone disease.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.
Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
› Verified 2 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Researchers from the University of Zurich and University Children's Hospital Zurich have discovered the first X-chromosome-inherited type of the congenital disease osteogenesis imperfecta, also known as brittle-bone disease.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.
Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
› Verified 2 days ago
| Entity Name | The Association Of Chrmc And University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255449963 PECOS PAC ID: 9133032964 Enrollment ID: O20031107000585 |
News Archive
Researchers from the University of Zurich and University Children's Hospital Zurich have discovered the first X-chromosome-inherited type of the congenital disease osteogenesis imperfecta, also known as brittle-bone disease.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.
Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Thomas Buckley, MD 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: (808) 433-2806 | Dr Robert Thomas Buckley, MD 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: (808) 433-2806 |
News Archive
Researchers from the University of Zurich and University Children's Hospital Zurich have discovered the first X-chromosome-inherited type of the congenital disease osteogenesis imperfecta, also known as brittle-bone disease.
UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.
Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
› Verified 2 days ago
Dr. William Carlton Jr., M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 352-294-5220 Fax: 352-392-8413 | |
David Shin, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 888-683-2778 |